Cognitive deficits often persist beyond remission in major depressive disorder (MDD). CDP-choline has shown improvements in cognition in other populations characterized by cognitive deficits. These improvements may be due to interactions with the glutamatergic and cholinergic systems. The aim of this ongoing study was to assess the neurochemical response through magnetic resonance spectroscopy to the acute administration of CDP-choline compared with placebo in the anterior cingulate in a group of remitted MDD participants. Early results indicate possible relationships between glutamate and myo-inositol concentrations, and CDP-choline.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords